Results 51 to 60 of about 5,466 (169)

A data-driven financial justification for an outpatient infectious diseases pharmacist

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
We present a financial justification for an outpatient infectious diseases pharmacist, based on cost savings from decreases in length of stay for patients with Staphylococcus aureus infections and additional revenue generated by physicians and ...
Justin J. Kim   +4 more
doaj   +1 more source

Sustained Treatment Success With Ustekinumab in Symptomatic Stricturing Crohn's Disease: A Retrospective Single‐Arm Observational Cohort Study

open access: yesMedComm, Volume 7, Issue 7, July 2026.
Data on ustekinumab (UST) for symptomatic stricturing Crohn's disease remain scarce in China. This cohort study screened 73 patients from June 2022 to April 2024, of whom 54 were eligible included, with 81.5% achieving 52‐week treatment success. Most attained sustained clinical remission alongside improved inflammation and strictures. Nonsmoking status
Jingwen Liu   +5 more
wiley   +1 more source

Inappropriateness of Intravenous Antibiotic Prescriptions at Hospital Discharge at a Tertiary Care hospital in Thailand

open access: yesDrug, Healthcare and Patient Safety, 2019
Tuanjai Mahatumarat,1 Napaporn Pinmanee,2 Wichchulada Injai,2 Romanee Chaiwarith1 1Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 2Division of Pharmacy, Maharaj Nakorn Chiang Mai
Mahatumarat T   +3 more
doaj  

Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections

open access: yesFrontiers in Medicine, 2020
Since the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has been a viable option for patients who require intravenous antibiotics when hospitalization is not warranted.
Tristan Ferry   +12 more
doaj   +1 more source

Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection

open access: yesFrontiers in Medicine, 2023
ObjectiveOutpatient parenteral antimicrobial therapy (OPAT) is a well-established and cost-effective method for improving the efficient use of healthcare resources. However, only a few centres in Germany perform it.
Fatma Kilinc   +12 more
doaj   +1 more source

Development and Physicochemical Stability of an Oral GS‐441524 Suspension for Weight‐Adjusted Treatment of Feline Infectious Peritonitis

open access: yesVeterinary Medicine and Science, Volume 12, Issue 4, July 2026.
A 50 mg/mL oral GS‑441524 suspension for feline infectious peritonitis (FIP) was developed and shown to remain physico‐chemically stable for at least 12 weeks under tested storage conditions and 28 days in‑use, supporting accurate weight‑adjusted dosing as an extemporaneously compounded formulation under veterinary supervision.
Cédric Wernli, Ursula Streit
wiley   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 24: Suitability of taxonomic units notified to EFSA until March 2026

open access: yesEFSA Journal, Volume 24, Issue 7, July 2026.
Abstract The Qualified Presumption of Safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ)   +26 more
wiley   +1 more source

To Discharge or Not to Discharge on Outpatient Parenteral Antimicrobial Therapy: That Is the Question [PDF]

open access: yesHospital Pediatrics, 2019
Outpatient parenteral antimicrobial therapy (OPAT) has gained traction since the 1970s as a means of delivering intravenous (IV) antibiotic therapy in home or ambulatory settings. OPAT is relatively safe and more cost-effective than hospital administration of IV antibiotics.1–4 Yet the initiation of OPAT requires thoughtful consideration of individual ...
Jessica L, Markham, Jennifer L, Goldman
openaire   +2 more sources

The OPAT opportunity for beta-lactam individualization

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Beta-lactam therapeutic drug monitoring has been growing in prevalence in the acute care hospital setting. Expansion of its use to outpatient parenteral antimicrobial therapy requires careful consideration of potential logistical and therapeutic barriers.
Lindsey M. Childs-Kean   +4 more
doaj   +1 more source

Outpatient parenteral ­antimicrobial therapy (OPAT) and the general ­physician [PDF]

open access: yesClinical Medicine, 2013
Outpatient parenteral antimicrobial therapy (OPAT) refers to outpatient or community-based management of an infection via the administration of an intravenous (IV) antimicrobial without an overnight hospital stay. Patients may be managed without admission or may transition to OPAT following hospitalisation.
Gavin Barlow, DA Barr, RA Seaton
openaire   +2 more sources

Home - About - Disclaimer - Privacy